Physician profile
Collin Kitchell
NPI 1275945800
$3,740.06
in general payments reported to CMS, 2019-2025
35 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,926 · 2020: $1,187 · 2021: $71.63 · 2022: $12.97 · 2023: $197 · 2024: $196 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $490.83 | 2019-2021 | |
| Novo Nordisk INC | $399.15 | 2019-2025 | Wegovy, Ozempic |
| Amarin Pharma, INC. | $318.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $288.82 | 2019-2020 | |
| Pfizer INC. | $281.92 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $214.21 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $156.21 | 2019-2020 | |
| Astellas Pharma US INC | $144.28 | 2019-2023 | Veozah |
| Lilly USA, LLC | $132.56 | 2019-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.99 | 2019-2020 | |
| Glaxosmithkline, LLC. | $122.05 | 2019-2020 | |
| Daiichi Sankyo INC. | $119.41 | 2019-2020 | |
| Radius Health, INC. | $85.97 | 2023-2024 | Tymlos |
| Medline Industries Lp | $82.66 | 2019 | |
| Exact Sciences Corporation | $74.64 | 2024-2025 | Cologuard Collection Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $67.06 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $62.58 | 2025 | Gemtesa |
| Sanofi Pasteur INC. | $54.40 | 2019 | |
| Eisai INC. | $50.08 | 2020 | |
| Tosoh Bioscience, INC. | $50.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.43 | 2020-2023 | |
| Abbvie INC. | $43.24 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $40.81 | 2019 | |
| Seqirus USA INC | $36.32 | 2019-2020 | |
| Esperion Therapeutics, INC. | $36.06 | 2020 | |
| Mayne Pharma Commercial LLC | $34.63 | 2024 | |
| Organon LLC | $25.86 | 2024 | |
| Bioventus LLC | $24.58 | 2020 | |
| Bausch Health US, LLC | $23.51 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.08 | 2019 | |
| Vivus LLC | $21.07 | 2019 | |
| Vertiflex, INC. | $19.20 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.45 | 2019 | |
| Genentech USA, INC. | $15.30 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Kitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.